Highest standard for Global Public Health

At MMGH, we strive for excellence. Our work consistently meets the highest quality standards required to be published in highly rated peer-reviewed journals. This outcome serves as a testament to the rigour and quality of our work.

Filters

Publication - Type
  • All Publications
  • Journal Article
  • Report
  • Other
  • Book
Years
  • All
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
Publications - Authors
  • Stefano Malvolti
  • Thomas Cherian
  • Melissa Ko
  • Carsten Mantel
  • Melissa Malhame
  • Adam Soble
  • Claire Hugo
  • Shawn Gilchrist
Search
Sort By (Publications)
MI4A produces antigen-specific market studies, analyzing global demand and supply dynamics for products targeting a specific antigen. The Global Market Study on RSV Immunization Products aims to identify early potential...
Publication
WHO
MMGH Authors
Read Publication
Measles and rubella micro-array patches (MR-MAPs) are a promising innovation to address limitations of the current needle and syringe (N&S) presentation due to their single-dose presentation, ease of use, and...
Publication
MDPI
MMGH Authors
Read Publication
As an innovative vaccine delivery technology, vaccine microarray patches could have a meaningful impact on routine immunization coverage in low- and middle-income countries, and vaccine deployment during epidemics and pandemics....
Publication
Vaccine
MMGH Authors
Read Publication
Background: Microarray patches (MAPs) are a promising technology being developed to reduce barriers to vaccine delivery based on needles and syringes (N&S). To address the evidence gap on the public...
Publication
BMJ Global Health
MMGH Authors
Read Publication
There is growing interest from governments, donors and implementing partners to introduce and scale-up digital health interventions to support immunisation service delivery. A multi-country evaluation was performed with the aim...
Publication
TechNet-21
MMGH Authors
Read Publication
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 20-22 March 2023. This report summarises the discussions, conclusions and recommendations. It covers the following items: Global...
Publication
World Health Organisation
MMGH Authors
Read Publication
The global COVID-19 vaccination response provides many lessons on how to better prepare for and respond to future pandemics that require rapid, large-scale vaccination. This document includes a collection of...
Publication
The COVID-19 Vaccination Response: Country experiences, best practices, and lessons
MMGH Authors
Read Publication
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization...
Publication
World Health Organisation
MMGH Authors
Read Publication
Partnerships are fundamental to progress in immunization, and this is especially true for human papillomavirus (HPV) vaccination, which must be delivered in the context of a broader immunization, sexual and...
Publication
Vaccine
MMGH Authors
Read Publication
The global COVID-19 vaccination rollout is the biggest and fastest in history and no public health intervention compares to it. Under extraordinary time constraints and severe programmatic challenges, in 2021...
Publication
TechNet-21
MMGH Authors
Read Publication
This hybrid meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) was held from Monday 3 to Thursday 6 October 2022 inclusive. The agenda items included: Session 1...
Publication
World Health Organisation
MMGH Authors
Read Publication
Pharyngitis, more commonly known as sore throat, is caused by viral and/or bacterial infections. Group A Streptococcus (Strep A) is the most common bacterial cause of pharyngitis. Strep A pharyngitis...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S5-S14
MMGH Authors
Read Publication
Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A Streptococcus (Strep A) and Staphylococcus aureus, alone or in combination, with...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S15-S24
MMGH Authors
Read Publication
Cellulitis is an acute bacterial infection of the dermis and subcutaneous tissue usually found complicating a wound, ulcer, or dermatosis. This article provides guidelines for the surveillance of cellulitis. The...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S25-S30
MMGH Authors
Read Publication
Invasive group A streptococcal (Strep A) infections occur when Streptococcus pyogenes, also known as beta-hemolytic group A Streptococcus, invades a normally sterile site in the body. This article provides guidelines...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S31-S40
MMGH Authors
Read Publication
Acute rheumatic fever (ARF) is a multiorgan inflammatory disorder that results from the body’s autoimmune response to pharyngitis or a skin infection caused by Streptococcus pyogenes (Strep A). Acute rheumatic...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S41-S49
MMGH Authors
Read Publication
Rheumatic heart disease (RHD) is a long-term sequela of acute rheumatic fever (ARF), which classically begins after an untreated or undertreated infection caused by Streptococcus pyogenes (Strep A). RHD develops...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S50-S56
MMGH Authors
Read Publication
Acute poststreptococcal glomerulonephritis (APSGN) is an immune complex-induced glomerulonephritis that develops as a sequela of streptococcal infections. This article provides guidelines for the surveillance of APSGN due to group A...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S57-S64
MMGH Authors
Read Publication
Across the Gavi Alliance millions are spent on in-service training and supportive supervision as a primary approach for improving health worker learning and performance management despite weak evidence of impact...
Publication
Gavi, The Vaccine Alliance
MMGH Authors
Read Publication
Background Progress towards measles and rubella (MR) elimination has stagnated as countries are unable to reach the required 95% vaccine coverage. Microarray patches (MAPs) are anticipated to offer significant programmatic...
Publication
medRxiv Volume 8, Issue 11, pp. 1-37
MMGH Authors
Read Publication
This section contains country experiences on COVID-19 vaccination, from the initial planning to the implementation. These are valuable sources of information on approaches and solutions for some of the common...
Publication
TechNet-21
MMGH Authors
Read Publication
The past two decades have seen important progress in access to timely, reliable, affordable, and quality-assured supplies of vaccines of global public health importance. The new vaccines developed are powerful...
Publication
Vaccine
MMGH Authors
Read Publication
Background: A pressing need exists to develop vaccines for neglected diseases, including leishmaniasis. However, the development of new vaccines is dependent on their value to two key players–vaccine developers and...
Publication
PLOS Neglected Tropical Diseases Volume 16, Issue 6, pp. 10471-10487
MMGH Authors
Read Publication
Background: The “Ending Cholera: A Global Roadmap to 2030” (Roadmap) was launched in October 2017. Following its launch, it became clear that additional evidence is needed to assist countries in...
Publication
PLOS ONE Volume 17, Issue 5, pp. 264952-264963
MMGH Authors
Read Publication
Historically, clinical development and approval of vaccines have spanned approximately 10 years with only ~16% of vaccine candidates ever receiving market authorisation. The long timelines and the low success rates...
Publication
Wellcome Trust
MMGH Authors
Read Publication
World Health Organisation (WHO) preferred product characteristics describe preferences for product attributes that would help optimise value and use to address global public health needs, with a particular focus on...
Publication
Vaccine Volume 40, Issue 26, pp. 3506-3510
MMGH Authors
Read Publication
As result of the C-19 pandemic renewed attention has been focused on vaccine manufacturing capacity and self-sufficiency. The PROSUR member states (Argentina, Brazil, Chile, Colombia, Ecuador, Guyana, Peru, Paraguay) required...
Publication
PROSUR
MMGH Authors
Read Publication
Background Non-typhoidal salmonella can cause serious, life-threatening invasive infections involving the bloodstream and other normally sterile sites. We aimed to systematically review the prevalence of complications and case-fatality ratio (CFR)...
Publication
The Lancet Infectious Disease Volume 22, Issue 5, pp. 692-705
MMGH Authors
Read Publication
Background: Non-typhoidal salmonella can cause serious, life-threatening invasive infections involving the bloodstream and other normally sterile sites. We aimed to systematically review the prevalence of complications and case-fatality ratio (CFR)...
Publication
The Lancet, Infectious Diseases
MMGH Authors
Read Publication
Immunization prevents 4 to 5 million deaths annually, primarily among children, but each year 20 million infants do not receive a full course of the most essential basic vaccines. COVID-19...
Publication
Science, Volume 374, Issue, 6574, pp. 1438-1441
MMGH Authors
Read Publication
The European Vaccine Action Plan 2015–2020 has set a course to control, eliminate or eradicate vaccine-preventable diseases in the WHO European Region. The insistence of the Region’s Member States to...
Publication
World Health Organisation
MMGH Authors
Read Publication
Background: To inform the World Health Organisation’s full value of vaccine assessment for group B Streptococcus (GBS) vaccines, a rapid literature appraisal was conducted to inform the operationalisation of maternal...
Publication
Clinical Infectious Diseases Volume 74, Issue Supplement 1, pp. S80–S87
MMGH Authors
Read Publication
Background: Despite group B Streptococcus (GBS) being a leading cause of maternal and infant morbidity and mortality, no vaccine is currently available. To inform vaccine developers, countries, and funders, we...
Publication
Clinical Infectious Diseases Volume 74, Issue Supplement 1, pp. S70–S79
MMGH Authors
Read Publication
Introduction The leishmaniases represent a group of parasitic diseases caused by infection with one of several species of Leishmania parasites. Disease presentation varies because of differences in parasite and host...
Publication
Expert Review of Vaccines, Volume 20, Issue 11, pp. 1419-1430
MMGH Authors
Read Publication
Immunisation is among the most cost-effective public health interventions available and is estimated to have averted at least 37 million deaths between 2000 and 2019. Since the establishment of the...
Publication
The Journal of Infectious Diseases Volume 224, Issue Supplement 4, pp. S452-S467
MMGH Authors
Read Publication
The development of vaccines against one or all forms of human leishmaniasis remains hampered by a paucity of investment, at least in part resulting from the lack of well-evidenced and...
Publication
PLOS Neglected Tropical Diseases Volume 15, Issue 9, pp. 9742-9760
MMGH Authors
Read Publication
Founded in 2017, the Coalition for Epidemic Preparedness Innovations (CEPI) is an international partnership that finances and coordinates the development of new vaccines to prevent and contain infectious disease epidemics...
Publication
Coalition for Epidemic Preparedness Innovation
MMGH Authors
Read Publication
Vaccines are recognised as one of the most cost-effective public health interventions available, yet the global vaccine ecosystem is not structured to fully realise their potential to improve health. Systemic...
Publication
The Sabin-Aspen Vaccine Science & Policy Group
MMGH Authors
Read Publication
In September 2020, the World Health Organization, with the advice of the CSCS Task Force, commissioned an assessment of the Covid-19 Supply Chain System (CSCS) focused on three main areas:...
Publication
World Health Organisation
MMGH Authors
Read Publication
When the Sabin-Aspen Vaccine Science & Policy Group decided in 2019 to consider ways to improve the research and development (R&D) component of the vaccine/vaccination ecosystem, SARS-CoV-2 (formally, severe acute...
Publication
Sabin-Aspen Vaccine Science & Policy Group
MMGH Authors
Read Publication
The Cholera Roadmap Research Agenda identifies knowledge gaps most important to cholera experts and stakeholders and establishes a prioritised list of research questions that, when answered, will have a significant...
Publication
The Global Task Force on Cholera Control
MMGH Authors
Read Publication
Measles remains a major cause of morbidity and mortality worldwide, with an estimated 9.7 million cases and more than 140,000 measles-related deaths in 2018. It is one of the most...
Publication
World Health Organisation
MMGH Authors
Read Publication
ViPS and Ty21a markets are largely focused on the private sector and travellers markets. Given the product characteristics of TCV, it is anticipated that demand for these markets will decrease...
Publication
World Health Organisation
MMGH Authors
Read Publication
Objective: An independent external evaluation of the International Clinical Epidemiology Network (INCLEN) research programme to emphasise the public health significance of childhood pneumonia in India. Method: An independent evaluation based...
Publication
Indian Pediatrics Volume 58, Issue 11, pp. 1074-1076
MMGH Authors
Read Publication
The global vaccine ecosystem does not optimally realise vaccines’ potential to deliver health improvements. With this research effort, Wellcome aims to identify solutions that will improve the vaccine ecosystem, focusing...
Publication
Wellcome Trust
MMGH Authors
Read Publication
The Monitoring & Evaluation/Accountability (M&E/A) framework to assess progress was a critical element of the Global Vaccine Action Plan 2012–2020 (GVAP) and was seen by many as a game changer....
Publication
Vaccine Volume 38, Issue 33, pp. 5384-5386
MMGH Authors
Read Publication
Introduction: The Monitoring & Evaluation/Accountability (M&E/A) framework of the Global Vaccine Action Plan (GVAP) was used to report progress annually to the World Health Assembly (WHA). Methods: Stakeholder feedback was...
Publication
Vaccine Volume 38, Issue 33, pp. 5379-5383
MMGH Authors
Read Publication
Introduction: The Global Vaccine Action Plan (GVAP), unanimously endorsed by the World Health Assembly in 2012, defined an ambitious strategy to improve immunisation. At the end of the decade, significant...
Publication
Vaccine Volume 38, Issue 33, pp. 5372-5378
MMGH Authors
Read Publication
Objectives: To examine the characteristics of existing maternal tetanus immunisation programmes for pregnant women in low- and middle-income countries (LMICs) and to identify and understand the challenges, barriers and facilitators...
Publication
Vaccine Volume 38, Issue 33, pp. 5268-5277
MMGH Authors
Read Publication
Human visceral leishmaniasis (VL) vaccines are currently under development and there is a need to understand their potential impact on population wide VL incidence. We implement four characteristics from different...
Publication
PLOS Neglected Tropical Diseases Volume 14, Issue 7, pp. 8460-8480
MMGH Authors
Read Publication
National introduction of PCV in infant routine immunisation in 42 countries – including large ones like India, China and Indonesia – will trigger an increase of demand in excess of...
Publication
World Health Organisation
MMGH Authors
Read Publication
As of November 2023, 140 World Health Organization (WHO) member states had introduced human papillomavirus (HPV) vaccination in their routine immunization schedules. Despite a continuously increasing demand from countries across...
Publication
Vaccines
MMGH Authors
Read Publication
MI4A produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk for sustainable access to vaccine supply and define mitigating actions....
Publication
World Health Organisation
MMGH Authors
Read Publication
New report outlines pathways to protect mothers and infants from one of the most common causes of severe infant respiratory infections worldwide...
Publication
PATH
MMGH Authors
Read Publication
From the development of each vaccine to its use in reducing disease, Plotkin’s Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This...
Publication
Vaccines, Seventh Edition
MMGH Authors
Read Publication